Evidence map›Paper›PMID 29017285›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Reply to Corona and Cattaneo.

Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis, Alan Forrest, David L Paterson, Jian Li, Fernanda P Silveira

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Roger L NationDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
Samira M GaronzikSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York.
Visanu ThamlikitkulDivision of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Evangelos J Giamarellos-BourboulisFourth Department of Internal Medicine, University of Athens Medical School, Greece.
Alan ForrestSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York.
David L PatersonUniversity of Queensland Center for Clinical Research, Royal Brisbane and Women's Hospital, Australia.
Jian LiDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
Fernanda P SilveiraDivision of Infectious Diseases, University of Pittsburgh Medical Center, Pennsylvania.

Funding

Optimizing Dosing of Colistin for Infections Resistant to all Other AntibioticsR01AI070896 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SILVEIRA, FERNANDA P. · 2007 to 2011
$3.6M
NIAID NIH HHS R01 AI070896
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ColistinCritical IllnessHumansColistin

Identifiers

PMID29017285
PMCPMC5849108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.